BioSpace News Archive

Madrigal Pharmaceuticals, Inc. today provides a summary of corporate updates and reports fourth quarter and full year 2022 financial results.

Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company and minority stakeholder in BT BeaMed Technologies (“BeaMed”), is pleased to inform shareholders that development of the BeaMed StingRay Laser System (the “StingRay System”) is progressing smoothly and ahead of estimated schedule.

PharmAla Biotech is pleased to announce the publication of a key Patent Cooperation Treaty application containing 6 Novel Chemical Entities.

Ardelyx, Inc. today announced it will hold a conference call on Thursday, March 2, 2023, at 4:30 p.m. Eastern Time to discuss fourth quarter and full year 2022 financial results and provide a business update.

Pasithea Therapeutics Corp. today announced that Lawrence Steinman, Pasithea’s Chairman and National Academy of Sciences Professor, will deliver the Dr. Kenneth P. Johnson lecture at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) on February 23 in San Diego, California.

OKYO Pharma Limited announces the appointment of Jay S. Pepose, M.D., Ph.D., Founder and Medical Director of the Pepose Vision Institute and Professor of Clinical Ophthalmology at Washington University School of Medicine, to OKYO’s Scientific Advisory Board.

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, announced positive 12-month findings from the SOLAR study.

Biophytis SA announced it is convening an Extraordinary and Ordinary Shareholders’ Meeting for March 30, 2023.

Genus, a leading global animal genetics company, announces its interim results for the six months ended 31 December 2022.

AtlantiCare is the first healthcare system in the northeastern U.S. to use Optellum’s Virtual Nodule Clinic.